Cleared Traditional

K833781 - DURAZYME CPK

K833781 is the FDA 510(k) clearance for DURAZYME CPK by American Monitor Corp.. It is a Class 2 Chemistry device (product code CGS) cleared through the Traditional 510(k) pathway after a 82-day FDA review.

K833781 · American Monitor Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
82d
Days
Class 2
Risk

K833781 is an FDA 510(k) clearance for the DURAZYME CPK. Classified as Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (product code CGS), Class II - Special Controls.

Submitted by American Monitor Corp. (Mchenry, US). The FDA issued a Cleared decision on January 18, 1984 after a review of 82 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Monitor Corp. devices

Submission Details

510(k) Number K833781 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 1983
Decision Date January 18, 1984
Days to Decision 82 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 88d · This submission: 82d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes

All 99
Devices cleared under the same product code (CGS) and FDA review panel - the closest regulatory comparables to K833781.
SIGMA PROCEDURE 47-UV
K842013 · Sigma Chemical Co. · Jun 1984
CREATINE KINASE MB REAGENT
K840783 · American Dade · Apr 1984
CK-NAC REAGENT
K834502 · Roche Diagnostic Systems, Inc. · Feb 1984
CREATINE KINASE REAGENT CK LTS
K831965 · Electro-Nucleonics Laboratories, Inc. · Sep 1983
PARAMAX CREATINE KINASE REAGENT
K831537 · American Dade · Jun 1983
ULTRAZYME PLUS CKI, #64978,65027&65028
K821473 · Emd Chemicals, Inc. · Jun 1982